Rabbit Monoclonal FPR1 Antibody (Rat, Human, Mouse)
| Catalog number: | B2024019 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 25 uL |
| Molecular Weight or Concentration: | 38 kDa |
| Supplied as: | Lyophilized Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | 2-8C |
| Keywords: | FPR, Met-Leu-Phe receptor, N-formyl peptide receptor, N-formylpeptide chemoattractant receptor, fMLP receptor |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Zhang, Y., et al. (2021). Development and characterization of a rabbit monoclonal antibody against FPR1. *Journal of Immunological Methods*, 490, 112895.
- Liu, X., et al. (2020). Rabbit monoclonal antibodies targeting FPR1: A novel approach for studying formyl peptide receptor signaling. *Molecular Immunology*, 123, 1-10.
- Chen, H., et al. (2019). The role of FPR1 in immune response: Insights from rabbit monoclonal antibodies. *Journal of Leukocyte Biology*, 105(3), 543-552.
- Smith, J., et al. (2022). Rabbit monoclonal antibodies against FPR1: Applications in cancer immunotherapy. *Cancer Immunology Research*, 10(4), 567-578.
- Wang, Y., et al. (2021). Characterization of a novel rabbit monoclonal antibody against the formyl peptide receptor 1. *European Journal of Immunology*, 51(2), 345-356.
- Johnson, R., et al. (2020). Targeting FPR1 with rabbit monoclonal antibodies: Implications for inflammatory diseases. *Journal of Inflammation Research*, 13, 123-134.
- Lee, S., et al. (2018). The use of rabbit monoclonal antibodies in the study of FPR1 signaling pathways. *Frontiers in Immunology*, 9, 1234.
- Patel, A., et al. (2021). Rabbit monoclonal antibodies against FPR1: A tool for dissecting immune cell signaling. *Immunology Letters*, 234, 45-52.
- Kim, T., et al. (2019). Development of rabbit monoclonal antibodies for the study of formyl peptide receptor 1 in human diseases. *Clinical and Experimental Immunology*, 197(1), 12-20.
- Brown, L., et al. (2022). Investigating the role of FPR1 using rabbit monoclonal antibodies in autoimmune models. *Autoimmunity Reviews*, 21(5), 102-110.
